MetaCap

Cellectis S.A. Statistics

NASDAQ: CLLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.9209-0.0789 (-7.89%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Cellectis S.A. by the numbers

Cellectis S.A. has a market capitalization of $92.8 million based on 72.73M shares outstanding. With trailing EPS of $-1.26, Cellectis S.A. is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 25.3% below its 50-day average and 67.7% below its 200-day average.

Average daily trading volume is 115.00K shares, or about $105,900 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CLLS valuation vs. peer median

CLLS compared with the median of 8 peer companies
MetricCLLSPeer medianDifference
Market cap$92.76M$94.23M-2%
Avg. volume115.00K739.73K-84%

Peer median across 8 companies: DERM, CATX, NTHI, NRXP, PDSB, NBP, UNCY, CPIX.

Valuation

Market cap
$92.76M
Price / sales (latest FY)
1.27
EPS (TTM)
$-1.26

Price and trading

Previous close
0.9998
Open
0.99
Day range
0.9028 – 0.9957
52-week range
0.881 – 5.45
52-week change
-80.36%
Beta
—
Volume
52.63K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
92.76M
Forward Pe
-1.67
Eps
-1.26
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
5.45
Week52 Low
0.88
Avg Volume
115.00K
Shares Outstanding
72.73M
Ma50
1.23
Ma200
2.85
Earnings Date
Nov 12, 2026
Pct From52w High
-83.10%
Pct From52w Low
4.53%

Related